SHILPA MEDICARE
Quarterly Results Analysis [Dec2023]
SHILPA MEDICARE Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹286 Cr | ₹313 Cr | ₹260 Cr | ₹264 Cr | ₹262 Cr | ₹263 Cr | ₹261 Cr | ₹341 Cr |
Expenses | ₹221 Cr | ₹253 Cr | ₹212 Cr | ₹225 Cr | ₹231 Cr | ₹251 Cr | ₹241 Cr | ₹267 Cr |
Operating Income | ₹66 Cr | ₹60 Cr | ₹48 Cr | ₹38 Cr | ₹31 Cr | ₹12 Cr | ₹21 Cr | ₹74 Cr |
Other Income | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹8 Cr | ₹5 Cr |
Interest | ₹26 Cr | ₹23 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹13 Cr | ₹10 Cr | ₹9 Cr |
Depreciation | ₹27 Cr | ₹28 Cr | ₹27 Cr | ₹26 Cr | ₹24 Cr | ₹23 Cr | ₹22 Cr | ₹22 Cr |
Profit Before Tax | ₹15 Cr | ₹11 Cr | ₹5 Cr | ₹-3 Cr | ₹-8 Cr | ₹-20 Cr | ₹-3 Cr | ₹47 Cr |
Profit After Tax | ₹6 Cr | ₹3 Cr | ₹3 Cr | ₹-7 Cr | ₹-7 Cr | ₹-16 Cr | ₹3 Cr | ₹31 Cr |
EPS | ₹0.53 | ₹0.19 | ₹0.14 | ₹-0.93 | ₹-0.76 | ₹-2.15 | ₹0.10 | ₹3.40 |
Industry Peers & Returns | 1W | 1M | 1Y |
SHILPA MEDICARE | 0.8% | 1.1% | 84% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
SHILPA MEDICARE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -8.47 % |
Y-o-Y | 9.14 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹286 Cr | -8.47 | |
Sep2023 | ₹313 Cr | 20.29 | |
Jun2023 | ₹260 Cr | -1.28 | |
Mar2023 | ₹264 Cr | 0.41 | |
Dec2022 | ₹262 Cr | -0.16 | |
Sep2022 | ₹263 Cr | 0.67 | |
Jun2022 | ₹261 Cr | -23.32 | |
Mar2022 | ₹341 Cr | - |
SHILPA MEDICARE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 9.37 % |
Y-o-Y | 110.78 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹66 Cr | 9.37 | |
Sep2023 | ₹60 Cr | 25.83 | |
Jun2023 | ₹48 Cr | 25.36 | |
Mar2023 | ₹38 Cr | 22.18 | |
Dec2022 | ₹31 Cr | 156.48 | |
Sep2022 | ₹12 Cr | -40.70 | |
Jun2022 | ₹21 Cr | -72.10 | |
Mar2022 | ₹74 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 19.46 % |
Y-o-Y | 93.12 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 23.02% | 19.46 | |
Sep2023 | 19.27% | 4.61 | |
Jun2023 | 18.42% | 27.03 | |
Mar2023 | 14.5% | 21.64 | |
Dec2022 | 11.92% | 156.90 | |
Sep2022 | 4.64% | -41.12 | |
Jun2022 | 7.88% | -63.60 | |
Mar2022 | 21.65% | - |
SHILPA MEDICARE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 65.70 % |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹6 Cr | 65.70 | |
Sep2023 | ₹3 Cr | 22.53 | |
Jun2023 | ₹3 Cr | Positive | |
Mar2023 | ₹-7 Cr | Negative | |
Dec2022 | ₹-7 Cr | Negative | |
Sep2022 | ₹-16 Cr | Negative | |
Jun2022 | ₹3 Cr | -89.93 | |
Mar2022 | ₹31 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 81.08 % |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 2.01 % | 81.08 | |
Sep2023 | 1.11 % | 1.83 | |
Jun2023 | 1.09 % | Positive | |
Mar2023 | -2.6 % | Negative | |
Dec2022 | -2.65 % | Negative | |
Sep2022 | -6.23 % | Negative | |
Jun2022 | 1.18 % | -86.85 | |
Mar2022 | 8.97 % | - |
SHILPA MEDICARE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 178.95 % |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹0.53 | 178.95 | |
Sep2023 | ₹0.19 | 35.71 | |
Jun2023 | ₹0.14 | Positive | |
Mar2023 | ₹-0.93 | Negative | |
Dec2022 | ₹-0.76 | Negative | |
Sep2022 | ₹-2.15 | Negative | |
Jun2022 | ₹0.1 | -97.06 | |
Mar2022 | ₹3.4 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD